We hypothesize, however, that even though these engineered T cells secrete anti-VEGF themselves, pre-conditioning the tumor vasculature with anti-VEGF may still be required to ensure efficient homing and infiltration of the CAR-T cells into the TME. This evidence concerns the gene VEGFA and neoplasm.